Back to top

Is ABUS set to rally? Crossed Above 200 Day Moving Average shows up after advancing 3.23%

Arbutus Biopharma Corporation (ABUS) Technical Analysis, Stock Scans & Trading Signals · Jul 23, 2026, 20:06 ET
ABUS posted a 3.23% gain on Thursday, July 23rd, accompanied by 0.7× normal trading volume. Multiple bullish signals emerged — Crossed Above 200 DMA and Stochastic Buy Signal — suggesting potential strength ahead. Key support levels exist at 4.32, 4.17 & 4.09, with resistance at 4.55, 4.63 & 4.78. Additionally, Slow Stochastic points to oversold territory, hinting at a potential consolidation.

Current SwingTradeBot Technical Rating of ABUS: C

Traders are watching ABUS for a reason. See the full signal list.

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Arbutus Biopharma Corporation (ABUS)